Variable | Local recurrence | Metastatic progression | ||||
HR | 95% CI | P value | HR | 95% CI | P value | |
Age | 0.99 | 0.97–1.01 | 0.3 | 0.99 | 0.97–1.0 | 0.2 |
Gender | 0.75 | 0.4–1.4 | 0.4 | 1.0 | 0.6–1.6 | 0.99 |
Tumour size | 1.1 | 0.99–1.2 | 0.06 | 1.1 | 1.0–1.1 | 0.03 |
Central renal lesion | 1.0 | 0.5–2.2 | 0.9 | 0.97 | 0.5–1.8 | 0.92 |
Positive surgical margins | 4.8 | 2–11.6 | 0.001 | 2.1 | 0.96–4.4 | 0.06 |
Pathology | ||||||
Necrotic tumour Capsular invasion | 1.1 2.1 | 0.6–2.2 1.1–4.2 | 0.7 0.03 | 2.3 1.4 | 1.3–3.8 0.8–2.4 | 0.001 0.2 |
Tumour stage (pT3–4 compared with pT1-T2) | 3.1 | 1.4–7 | 0.005 | 3.6 | 2.0–6.5 | 0.001 |
Variable | All-cause mortality | Disease-specific mortality | ||||
HR | 95% CI | P value | HR | 95% CI | P value | |
Age | 1.03 | 1.01–1.04 | 0.003 | 1.0 | 0.98–1.02 | 0.99 |
Gender | 0.8 | 0.6–1.2 | 0.3 | 0.9 | 0.5–1.6 | 0.6 |
Tumour size | 1.05 | 0.99–1.1 | 0.1 | 1.1 | 1.02–1.2 | 0.01 |
Central renal lesion | 0.7 | 0.4–1.2 | 0.3 | 0.7 | 0.3–1.5 | 0.37 |
Positive surgical margins | 1.3 | 0.6–2.9 | 0.5 | 2.4 | 1.1–5.5 | 0.03 |
Pathology | ||||||
Necrotic tumour Capsular invasion | 2.0 1.3 | 1.3–2.9 0.8–1.9 | 0.001 0.2 | 2.2 1.9 | 1.2–4.0 1.0–3.5 | 0.01 0.05 |
Tumour stage (pT3–T4 compared with pT1–T2) | 2.2 | 1.4–3.5 | 0.001 | 4.2 | 1.9–9.1 | 0.001 |